Search references for CDR132L. Phrases containing CDR132L
See searches and references containing CDR132L!CDR132L
Antisense RNA medical therapy
CDR132L is an antisense RNA therapy that inhibits MiR-132. It is developed by Cardior Pharmaceuticals to treat heart failure. Batkai, Sandor; Genschel
CDR132L
German cardiologist and entrepreneur
and PD Parameters of CDR132L". clinicaltrials.gov. 2022-03-09. Retrieved 2025-04-08. "Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced
Thomas_Thum
Non-coding RNA molecule
prevention of heart failure progression in hypertrophic heart disease. CDR132L is the first-in-class synthetic antisense oligonucleotide inhibitor targeting
MiR-132
travel, tourism, insurance
CDR132L
CDR132L
CDR132L
CDR132L
CDR132L
CDR132L
CDR132L
CDR132L
CDR132L
travel, tourism, insurance